Cryopreservation of umbilical cord blood: 1. Osmotically inactive volume, hydraulic conductivity and permeability of CD34(+) cells to dimethyl sulphoxide.

Umbilical cord blood (UCB) is an accepted treatment for the reconstitution of bone marrow function following myeloablative treatment predominantly in children and juveniles. Current cryopreservation protocols use methods established for bone marrow and peripheral blood progenitors cells that have largely been developed empirically. Such protocols can result in losses of up to 50% of the nucleated cell population: losses unacceptable for cord blood. The design of optimal cryopreservation regimes requires the development of addition and elution protocols for the chosen cryoprotectant; protocols that minimise damaging osmotic transients. The biophysical parameters necessary to model the addition and elution of dimethyl sulphoxide to and from cord blood CD34(+) cells have been established. An electronic particle counting method was used to establish the volumetric response of CD34(+) cells to changes in osmolality of the suspending medium. The non-osmotic volume of the cell was 0.27 of the cells isotonic volume. The permeation kinetics of CD34(+) cells to water and dimethyl sulphoxide were investigated at two temperatures, +1.5 and +20 degrees C. Values for the hydraulic conductivity were 3.2 x 10(-8) and 2.8 x 10(-7)cm/atm/s, respectively. Values for the permeability of dimethyl sulphoxide at these temperatures were 4.2 x 10(-7) and 7.4 x 10(-6)cm/s, respectively. Clonogenic assays indicated that the ability of CD34(+) cells to grow and differentiate was significantly impaired outside the limits 0.6-4x isotonic. Based on the Boyle van't Hoff plot, the tolerable limits for cell volume excursion were therefore 45-140% of isotonic volume. The addition and elution of cryoprotectant was modelled using a two-parameter model. Current protocols for the addition of cryoprotectant based on exposure at +4 degrees C would require additional time for complete equilibration of the cryoprotectant. During the elution phase current protocols are likely to cause CD34(+) cells to exceed tolerable limits. The addition of a short holding period during elution reduces the likelihood of this occurring.

[1]  R. Gosden,et al.  Osmotically inactive volume, hydraulic conductivity, and permeability to dimethyl sulphoxide of human mature oocytes. , 1999, Journal of reproduction and fertility.

[2]  H. Hempling,et al.  Osmotic properties of human lymphocyte , 1977, Journal of cellular physiology.

[3]  F. Arnaud,et al.  Permeation of glycerol and propane-1,2-diol into human platelets. , 1990, Cryobiology.

[4]  F. Kleinhans,et al.  Membrane permeability modeling: Kedem-Katchalsky vs a two-parameter formalism. , 1998, Cryobiology.

[5]  S. Goldmann,et al.  5% Me2SO is sufficient to preserve stem cells derived from cord blood. , 1998, Bone marrow transplantation.

[6]  S. Rowley,et al.  Hematopoietic stem cell cryopreservation: a review of current techniques. , 1992, Journal of hematotherapy.

[7]  C. Le Forestier,et al.  A simple, efficient washing procedure for cryopreserved human hematopoietic stem cells prior to reinfusion. , 1991, Bone marrow transplantation.

[8]  D. Pegg.  Viability assays for preserved cells, tissues, and organs. , 1989, Cryobiology.

[9]  J. Hows,et al.  Optimal cryopreservation of human umbilical cord blood. , 1996, Bone marrow transplantation.

[10]  L. Mcgann,et al.  Permeability of human granulocytes to water: rectification of osmotic flow. , 1989, Cryobiology.

[11]  L. Petz,et al.  Clinical bone marrow transplantation , 1983 .

[12]  J. Critser,et al.  Cutting Edge Communication: Osmometric and Permeability Characteristics of Human Placental/Umbilical Cord Blood CD34T+ Cells and Their Application to Cryopreservation , 2000 .

[13]  D. Pegg,et al.  Differences in the requirements for cryopreservation of porcine aortic smooth muscle and endothelial cells. , 2001, Tissue engineering.

[14]  M. Gordon,et al.  SOURCES OF HUMAN HEMATOPOIETIC STEM CELLS FOR TRANSPLANTATION-A REVIEW. , 1995, Cell transplantation.

[15]  J. S. Kim,et al.  The alterations of the activities of coagulation inhibitors and fibrinolytic factors in stored cord blood could affect the yield of progenitor cells during processing. , 1999, Journal of hematotherapy & stem cell research.

[16]  C. Hunt,et al.  The effects of osmotic stress on human platelets , 1985, Journal of cellular physiology.

[17]  E. Milford,et al.  Impact of racial genetic polymorphism on the probability of finding an HLA-matched donor. , 1995 .

[18]  R. Freshney,et al.  Culture of hematopoietic cells , 1994 .

[19]  D. Harris,et al.  Collection, separation and cryopreservation of umbilical cord blood for use in transplantation. , 1994, Bone marrow transplantation.

[20]  I. Heschel,et al.  COMPARISON OF OPTICAL MEASUREMENT AND ELECTRICAL MEASUREMENT TECHNIQUES FOR THE STUDY OF OSMOTIC RESPONSES OF CELL SUSPENSIONS , 1999 .

[21]  A. Hubel,et al.  Cryobiophysical characteristics of genetically modified hematopoietic progenitor cells. , 1999, Cryobiology.

[22]  K. Muldrew,et al.  Water permeability of human hematopoietic stem cells. , 1987, Cryobiology.

[23]  K. Takagi,et al.  Effects of long-term cryopreservation on hematopoietic progenitor cells in umbilical cord blood , 1999, Bone Marrow Transplantation.

[24]  J. Adamson,et al.  Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[25]  G. Marti,et al.  Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells. European Working Group on Clinical Cell Analysis. , 1998, Cytometry.

[26]  J. Hows,et al.  Optimal processing of human umbilical cord blood for clinical banking. , 1996, Experimental hematology.

[27]  CD34: structure, biology, and clinical utility. , 1996, Blood.

[28]  D. Sutherland,et al.  The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. , 1996, Journal of hematotherapy.

[29]  S. Glück,et al.  Predictive factors for long-term engraftment of autologous blood stem cells , 2000, Bone Marrow Transplantation.

[30]  H Korb,et al.  Magnetic activated cell sorting (MACS) — a new immunomagnetic method for megakaryocytic cell isolation: Comparison of different separation techniques , 1994, European journal of haematology.

[31]  D. Gao,et al.  Fundamental cryobiology of human hematopoietic progenitor cells. I: Osmotic characteristics and volume distribution. , 1998, Cryobiology.

[32]  J. Kurtzberg,et al.  Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. , 1989, The New England journal of medicine.

[33]  A. Katchalsky,et al.  Thermodynamic analysis of the permeability of biological membranes to non-electrolytes. , 1958, Biochimica et biophysica acta.

[34]  C. Hunt,et al.  Cryopreservation of umbilical cord blood: 2. Tolerance of CD34(+) cells to multimolar dimethyl sulphoxide and the effect of cooling rate on recovery after freezing and thawing. , 2003, Cryobiology.

[35]  J. Madrigal,et al.  Cord Blood Characteristics: Role in Stem Cell Transplantation , 2000 .

[36]  H. Nakauchi.  Hematopoietic stem cells: Are they CD34-positive or CD34-negative? , 1998, Nature Medicine.

[37]  T. Luft,et al.  Comparison of purity and enrichment of CD34+ cells from bone marrow, umbilical cord and peripheral blood (primed for apheresis) using five separation systems , 1995, Stem cells.